Johnson & Johnson (FRA:JNJ)
161.74
+0.38 (0.24%)
At close: Nov 10, 2025
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€570,643
Profits / Employee
€155,552
Market Cap
392.93B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
| Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
| Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
| Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
| Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Deutsche Post AG | 573,964 |
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,000 |
Johnson & Johnson News
- 1 day ago - See Which Of The Latest 13F Filers Holds JNJ - Nasdaq
- 1 day ago - Johnson & Johnson: 2 Recent FDA Wins And Earnings Beat Warrant 'Buy' Rating - Seeking Alpha
- 4 days ago - FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression - Benzinga
- 4 days ago - FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression - Benzinga
- 4 days ago - JNJ Gains FDA Nod for New DARZALEX Faspro Indication - GuruFocus
- 4 days ago - Johnson & Johnson: Dividends Don't Lie - Seeking Alpha
- 4 days ago - Johnson & Johnson (JNJ) Gains FDA Approval for DARZALEX FASPRO in HR-SMM - GuruFocus
- 5 days ago - DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma - PRNewsWire